Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Citi
Medtronic
McKinsey
Cipla
Cantor Fitzgerald

Generated: July 23, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,989,494

Try a free trialSee Plans and Pricing

« Back to Dashboard

Which drugs does patent 7,989,494 protect, and when does it expire?

Patent 7,989,494 protects FARYDAK and is included in one NDA.

This patent has forty-two patent family members in thirty countries.

Summary for Patent: 7,989,494
Title:Polymorphs of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E- -2-propenamide
Abstract: Polymorphic forms of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E- -2-propenamide free base and salts thereof are prepared by various processes.
Inventor(s): Acemoglu; Murat (Basel, CH), Bajwa; Joginder S. (Elmwood Park, NJ), Karpinski; Piotr (Lincoln Park, NJ), Papoutsakis; Dimitris (Acton, MA), Slade; Joel (Flanders, NJ), Stowasser; Frank (Murg, DE)
Assignee: Novartis AG (Basel, CH)
Application Number:12/302,564
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 7,989,494
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 7,989,494

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Novartis Pharms Corp FARYDAK panobinostat lactate CAPSULE;ORAL 205353-001 Feb 23, 2015 RX Yes No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Novartis Pharms Corp FARYDAK panobinostat lactate CAPSULE;ORAL 205353-002 Feb 23, 2015 RX Yes No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Novartis Pharms Corp FARYDAK panobinostat lactate CAPSULE;ORAL 205353-003 Feb 23, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,989,494

PCT Information
PCT FiledJune 07, 2007PCT Application Number:PCT/US2007/070561
PCT Publication Date:December 21, 2007PCT Publication Number: WO2007/146716

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
QuintilesIMS
Argus Health
Queensland Health
Express Scripts
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.